HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neuroleptic malignant syndrome associated with the use of carbidopa/levodopa for dystonia in persons with cerebral palsy.

AuthorsDwan Perry, Pravardhan Birthi, Sara Salles, Susan McDowell
JournalPM & R : the journal of injury, function, and rehabilitation (PM R) Vol. 4 Issue 5 Pg. 383-4 (May 2012) ISSN: 1934-1563 [Electronic] United States
PMID22613365 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Dopamine Agents
  • Levodopa
  • Carbidopa
Topics
  • Carbidopa (adverse effects, therapeutic use)
  • Cerebral Palsy (complications, drug therapy)
  • Child
  • Dopamine Agents (adverse effects, therapeutic use)
  • Drug Therapy, Combination
  • Dystonia (complications, drug therapy)
  • Follow-Up Studies
  • Humans
  • Levodopa (adverse effects, therapeutic use)
  • Male
  • Neuroleptic Malignant Syndrome (etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: